Stephen Glover

Company: ZyVersa

Job title: Co-Founder, Chairman & Chief Executive Officer

Seminars:

Breakfast C-Level Panel Discussion: Overcoming Challenges in the Field & Current Thoughts on Progress 9:00 am

Thinking outside the box when it comes to disease indications to identify and prioritize for inflammasome therapeutic success Balancing commercial considerations of drug development with unmet need across diseases How crucial is it to demonstrate differentiation from standards of care or other inflammasome inhibitors? Should you plan for comparative data with standards of care in…Read more

day: Day Two